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After Hurricane Jeanne in September 2004, surveil-
lance for mosquitoborne diseases in Gonaïves, Haiti, iden-
tified 3 patients with malaria, 2 with acute dengue
infections, and 2 with acute West Nile virus infections
among 116 febrile patients. These are the first reported
human West Nile virus infections on the island of
Hispaniola.
H
urricane Jeanne caused large-scale devastation in
Gonaïves, Haiti, on September 18, 2004. The US
Department of Health and Human Services assisted the
Haitian Ministry of Health by conducting a rapid field
assessment of health-related issues. Among the actions
recommended by the team was immediate epidemiologic
assistance from the Centers for Disease Control and
Prevention (CDC) to reinforce and expand epidemiologic
surveillance to identify as early as possible any emerging
epidemic or community health problems. Concern was
raised that the combination of flooding, loss of shelter, and
destruction of infrastructure would result in an outbreak of
mosquitoborne diseases. We conducted surveillance to
assess the extent of mosquitoborne diseases and monitor
for outbreaks of these diseases.
The Study
We established laboratory-based fever surveillance at
the 3 clinics providing healthcare in Gonaïves after the
passage of Hurricane Jeanne. Febrile patients (core tem-
perature ≥38.5°C when first assessed) were asked to pro-
vide blood for a serum sample and thick and thin malaria
smears. The attending physician recorded each patient’s
medical history, conducted a physical examination, and
reported the discharge diagnosis and the therapy that was
provided. We asked patients to return in 2 weeks so that a
convalescent-phase serum sample could be collected.
Malaria smears were stained and read by using stan-
dard methods (1) at CDC. To diagnose dengue, we used
nested PCR and the TaqMan assay to detect dengue viral
RNA in serum samples obtained <5 days after onset of
symptoms (2,3). In addition, we used an immunoglobulin
M (IgM) antibody-capture (MAC)–ELISA to detect anti-
dengue IgM antibodies in all serum specimens (4) at CDC.
A result was considered positive when optical density,
after comparison to negative serum and control antigen,
was >0.20. All serum specimens were also tested for the
presence of IgG antibodies to determine previous exposure
to flaviviruses by using an IgG ELISA. In paired samples,
a full titration of 4-fold dilutions of serum was used. The
endpoint titration of IgG was determined to assess sero-
conversion (5). Each plate was compared with a negative
control serum specimen. Because of cross-reactivity
between anti-flavivirus antibodies, we used a microsphere-
based immunoassay (MIA) with a quadratic discrimination
analysis (6) and a plaque reduction neutralization test
(PRNT) to distinguish between infecting flaviviruses. For
the PRNT, serial dilutions of heat-inactivated serum were
incubated with defined amounts of West Nile, Saint Louis
encephalitis, and dengue viruses 1–4 for 2 hours at room
temperature. The nonneutralized viral fraction was subse-
quently adsorbed onto a monolayer of Vero cells for 1
hour. The resultant plaques were counted and compared
with results for the control virus with no serum. The end-
point of the titration was the highest dilution of serum that
reduced the number of plaques 90% compared with the
control results.
From November 15 through December 22, 2004, 116
acutely febrile patients were identified and included in our
surveillance. Ages ranged from 4 months to 71 years
(median 4 years); 52% were female. All patients lived in
Gonaïves. Seventy-one patients (61%) appeared for treat-
ment with a chief complaint of fever with cough, 35 (30%)
had fever with no apparent source, 6 (5%) reported fever
with diarrhea, and 4 (3%) reported fever with rash. Patients
sought treatment a median of 3 days after the onset of fever
(range 0–28 days). In addition to fever, the most common-
ly reported symptoms were cough (77, 66%), abdominal
pain (57, 49%), and headache (56, 48%). Thirty-nine
patients (34%) had at least 1 clinical sign of dehydration;
16 patients (14%) were hypotensive on physical examina-
tion. No patients were jaundiced or had spontaneous hem-
orrhage. The most common clinical diagnoses were upper
respiratory infection (35, 30%), malaria (34, 29%), pneu-
monia (21, 18%), and typhoid fever (13, 11%). No cases of
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were treated with oral antimicrobial drugs; 13 patients
(11%) were prescribed chloroquine, and 2 patients (2%)
received an antihelminthic drug. All cases of suspected
malaria were diagnosed by patients’ clinical symptoms.
Suspected tuberculosis was confirmed in 1 patient by a
positive sputum smear. None of 116 patients was admitted
to a hospital.
Of the 116 thick and thin smears, 3 (3%) samples
showed a high level of parasitemia with Plasmodium falci-
parum. The 3 corresponding patients had fever with no
apparent source. Malaria was suspected in 2 of the patients
by their clinical symptoms; the third patient was thought to
have typhoid and was treated with trimethoprim-
sulfamethoxazole. 
Two patients (2%) had acute, secondary dengue infec-
tions that were confirmed as positive by both IgM and IgG
serologic tests. Both patients had a chief report of fever
with no source, but malaria was suspected by the attending
physician, and 1 patient was treated with chloroquine. We
were not able identify dengue viral particles in the serum
specimens of these patients. However, 79 patients (68%)
were positive for anti-dengue IgG, which suggests a high
level of flavivirus transmission in this area in the recent
past (Figure).
Two patients (2%) had MIA results consistent with
acute West Nile virus infection. The results were con-
firmed by PRNT (Table). Both patients were febrile in the
clinic; 1 was a 13-year-old boy and the other was an infant
girl <1 year of age. In addition to fever, the 13-year-old
reported headache and abdominal pain, while cough was
reported in the infant. Acute malaria was clinically diag-
nosed in both patients. The older child received chloro-
quine, while the younger child received only aceta-
minophen for fever control.
Conclusions
This surveillance program was established to assess
the incidence of vectorborne diseases in the wake of
Hurricane Jeanne. A total of 116 acutely febrile patients
had blood drawn to determine whether a mosquitoborne
disease was the etiologic agent of fever. An outbreak of
mosquitoborne disease was not detected during the period
of surveillance. Our data are consistent with previously
published reports, which indicate that the incidence of
arboviral infections rarely increases after water-related dis-
asters (e.g., floods, hurricanes) (7−9). However, malaria
outbreaks are common in such settings (9,10).
Despite the absence of an outbreak, our surveillance
did identify the ongoing transmission of 3 mosquitoborne
pathogens. Specifically, we diagnosed 3 cases of acute
malaria, 2 cases of acute dengue, and 2 cases of acute West
Nile virus infection. We also detected a high seropreva-
lence of dengue infections in children, which suggests sub-
stantial local dengue transmission in the Gonaïves area in
the recent past.
The high seroprevalence of dengue and the low smear-
positive rate of malaria from our surveillance were consis-
tent with previously reported studies in this region of Haiti
(11,12). The identification of 2 patients with positive West
Nile virus results in Haiti is new. The only other human
West Nile virus infections identified in the Caribbean
Basin were 1 case reported in a Cayman Islands resident in
2001 (13) and 2 cases reported in Cuba, 1 in 2003 and the
other in 2004 (14). This finding is not unexpected, howev-
er, because Komar et al. have identified West Nile virus in
bird species native to the Dominican Republic (15), locat-
ed to the east of Haiti on the island of Hispaniola.
The fact that the rate of West Nile virus infection was
equal to the rate of acute dengue infection among our par-
ticipants is of concern. Moreover, because both viruses can
cause a nonlocalizing fever, the potential for confusion
with malaria exists. Differentiating the cause of acute non-
localizing febrile illnesses by examining malaria smears
before initiating therapy, especially in an area with a histo-
ry of low smear positivity, is therefore important.
Mosquitoborne Infections after Hurricane Jeanne
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 2, February 2007 309
Figure. Results of immunoglobulin G (IgG) ELISA for antiflavivirus
antibodies among patients exhibiting fever, Gonaïves, Haiti,
October 2004 (n = 105). *Exact ages are not available for 11
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